SlideShare a Scribd company logo
CLINICAL PHARMACY
• Liver Function Tests
LFT’s
 PharmD Fourth year
• By- 2. Vaibhavi Bhatwadekar
15. Khushi Ladda
• Government college of pharmacy, Aurangabad
 Introduction
- anatomy and physiology
 Functions of liver
 Goals of test
 LFT’s
 Drug induced liver diseases
 Reference
INTRODUCTION-
Anatomy and physiology-
 Liver is the largest organ of the body, dark-reddish in colour.
 The liver is located in the upper right hand portion of the abdominal cavity,
Beneath the diaphragm and on top of the stomach, right kidney and intestine.
 Weighing about 1400-1600 grams in males and 1200-1400 gram in females.
 Liver is divided into two lobe that is right lobe and left lobe.
 Each lobe contains a number of lobules.
 Each lobule is made of the hepatic cells the hepatic cells are the major
functional cells in the liver.
 Hepatic cells are separated by sinusoids which form part of reticular
endothelial system.
 Bile canaliculi present between hepatic cells empty into bile ducts.
FUNCTIONS OF THE LIVER-
1. Metabolic functions : Liver actively participates in carbohydrate,
lipid, protein, mineral and vitamin metabolisms.
2. Excretory functions : Bile pigments, bile salts and cholesterol
are excreted in the bile into intestine.
3. Protective functions and detoxification : Kupffer cells of liver
perform phagocytosis to eliminate foreign compounds. Ammonia is
detoxified to urea. Liver is responsible for the metabolism of
xenobiotics (detoxification).
4. Hematological functions : Liver participates in the formation of
blood (particularly in the embryo), synthesis of plasma proteins
(including blood clotting factors) and destruction of erythrocytes.
5. Storage functions : Glycogen, vitamins A, D and B12 and trace
element iron are stored
GOALS OF THE LFT’S-
1. To detect the presence of liver disease.
2. To distinguish among different types of liver diseases.
3. To detect the level of the disease whether the mild, moderate or severe
4. To follow the response of the treatment.
5. LFT are employed for accurate diagnosis, to assess the severity of
damage, to judge prognosis and to evaluate the therapy.
LFT’S-
 The liver function tests are the biochemical investigations to assess the capacity of the
liver to carry out any of the function its performs.
 The major liver function tests may be classified as follows :
 1. Tests based on excretory function— Measurement of bile pigments, bile salts,
bromosulphthalein.
 2. Tests based on serum enzymes derived from liver—Determination of transaminases,
alkaline phosphatase, 5’-nucleotidase, J-glutamyltranspeptidase.
 3. Tests based on metabolic capacity— Galactose tolerance, antipyrine clearance.
 4. Tests based on synthetic functions— Prothrombin time, serum albumin.
 5. Tests based on detoxification—Hippuric acid synthesis.
 A byproduct of RBC breakdown.
 Inside the liver cells , the bilirubin is conjugated with glucouronic acid to make it water
soluble.
 High bilirubin levels are observed in gallstones, acute and chgronic hepatitis.
 Bilirubin pigment can be detected in serum, faeces and urine.
 i) Serum bilirubin estimation is based on van den Bergh diazo reaction by
spectrophotometric method. Diazo reagent consists of diazotised sulfanilic acid. Water-
soluble conjugated bilirubin gives direct van den Bergh reaction with diazo reagent within
one minute, whereas alcohol-soluble unconjugated bilirubin is determined by indirect van
den Bergh reaction. Addition of alcohol to the reaction mixture gives positive test for both
conjugated and unconjugated bilirubin pigment. The unconjugated bilirubin level is then
estimated by subtracting direct bilirubin value from this total value. The serum of normal
adults contains less than 1 mg/ dl of total bilirubin, out of which less than 0.25 mg/dl is
conjugated bilirubin. Bilirubin level rises in diseases of hepatocytes, obstruction to biliary
excretion into the duodenum, in haemolysis, and defects of hepatic uptake and
conjugation of bilirubin pigment such as in Gilbert’s disease.
 ii) In faeces, excretion of bilirubin is assessed by inspection of stools. Clay-coloured
stool due to absence of faecal excretion of the pigment indicates obstructive jaundice.
 iii) In urine, conjugated bilirubin can be detected by commercially available ‘dipsticks’,
Fouchet’s test, foam test or ictotest tablet method. Bilirubinuria does not occur in
normal subjects nor is unconjugated bilirubin excreted in the urine. Bilirubinuria occurs
only when there is raised level of conjugated bilirubin (filterable). Its excretion
depends upon the level of conjugated bilirubin in plasma that is not proteinbound and
is therefore available for glomerular filtration. Bilirubinuria appears in patients of
hepatitis before the patient becomes jaundiced.
 Serum bilirubin normal values:-
Total 0.3-1.3 mg/dl
Direct (conjugated) 0.1-0.4 mg/dl
Indirect (unconjugated) 0.2-0.9 mg/dl
 Urobilinogen is a clourless byproduct of bilirubin reduction.
 Urobilinogen is normally excreted in the urine.
 Its semiquantitative estimation in the urine can be done by preparing dilutions with
Ehrlich’s aldehyde reagent or by ‘dipstick’ method.
 An increase in urobilinogen in the urine is found in hepatocellular dysfunctions such
as in alcoholic liver disease, cirrhosis and malignancy of the liver.
 It is also raised in haemolytic disease and in pyrexia.
 In cholestatic jaundice due to complete biliary obstruction, urobilinogen disappears
from the urine
 Bromsulphalein (BSP) is a dye which is removed from circulation by the same
mechanisms of binding, conjugation and excretion as bilirubin.
 BSP is injected intravenously and a sample of venous blood 45 minutes later is tested
for percentage of injected dye remaining in the blood.
 The test is rarely performed nowadays because of the availability of enzyme
estimations which are better indicators of hepatic dysfunction.
 Presently, the only value of BSP excretion test is in the diagnosis of Dubin-Johnson’s
syndrome
 Serum alkaline phosphatase is produced by many tissues, especially bone, liver, intestine
and placenta and is excreted in the bile.
 Most of the normal serum alkaline phosphatase (range 33-96 U/L) is derived from bone.
 Elevation in activity of the enzyme can thus be found in diseases of bone, liver and in
pregnancy.
 In the absence of bone disease and pregnancy, an elevated serum alkaline phosphatase
levels generally reflect hepatobiliary disease.
 The greatest elevation (3 to 10 times normal) occurs in biliary tract obstruction. Slight to
moderate increase is seen in parenchymal liver diseases such as in hepatitis and cirrhosis
and in metastatic liver disease.
 It is possible to distinguish serum hepatic alkaline phosphatase from bony alkaline
phosphatase by fractionation into isoenzymes but this is not routinely done.
 The primary source of the enzyme, γ-GT, in serum is the liver.
 Its serum level parallels serum alkaline phosphatase and is used to confirm that the
elevated serum alkaline phosphatase is of hepatobiliary origin.
 Besides its elevation in cholestasis and hepatocellular disease, the levels are high in
patients with alcohol abuse even without liver disease.
 Normal:- 9-58 IU/L (15-85 U/L)
 i) Serum aspartate transaminase or AST (formerly glutamic oxaloacetic transaminase or
SGOT): AST or SGOT is a mitochondrial enzyme released from heart, liver, skeletal muscle
and kidney. Its normal serum level is 0.20-0.65 μkat/L (12-38 U/L).
 ii) Serum alanine transaminase or ALT (formerly glutamic pyruvic transaminase or
SGPT): ALT or SGPT is a cytosolic enzyme primarily present in the liver. Its normal serum level
is 0.12-0.70 μkat/L (7-41 U/L).
 Serum levels of SGOT and SGPT are increased on damage to the tissues producing them.
Thus serum estimation of SGPT (ALT) which is fairly specific for liver tissue is of greater value
in liver cell injury, whereas SGOT (AST) level may rise in acute necrosis or ischaemia of other
organs such as the myocardium, besides liver cell injury.
 Transaminase estimations are useful in the early diagnosis of viral hepatitis. Very high levels
are seen in extensive acute hepatic necrosis such as in severe viral hepatitis and acute
cholestasis. Alcoholic liver disease and cirrhosis are associated with mild to moderate elevation
of transaminases
 Albumin is solely synthesized by the liver.
 It has a half-life of about 20-25 days, therefore, it is a good marker to assess chronic
(and not acute) liver damage.
 Low serum albumin is commonly observed in patients with severe liver damage. It
must, however, be noted that the serum albumin concentration is also decreased due
to other factors such as malnutrition.
 Normal serum albumin level :- 3.5-5.5 g/dl
 Alpha and beta globulins are mainly synthesized by the liver.
 They constitute immunoglobulins .
 High serum gamma globulin are observed in chronic hepatitis and cirrhosis.
 Normal level;- 2.0-3.5 g/dl
 Normal Albumin to Globulin ratio(A/G) :- 1.5-3:1
 The liver synthesizes all the factors concerned with blood clotting.
 A decrease in the concentration of plasma clotting factors is found in the impairment of
liver function.
 This can be assessed in the laboratory by measuring prothrombin time which is
prolonged in patients with liver damage, compared to normal.
 The half-lives of clotting factors are relatively short (5-72 hrs.), therefore, changes in
prothrombin time occur quickly. Hence, this test is useful to assess acute as well as
chronic liver damages; besides its help in the prognosis.
 Vitamin K is required for the synthesis of blood clotting factors II, VII, IX and X.
Therefore, vitamin K deficiency can also cause prolonged prothrombin time which
must be ruled out, before drawing conclusions on the liver functions. This is done by
measuring prothrombin time before and after administration of vitamin K.
 The choice of biochemical tests to measure liver functions mostly depends on the
purpose of the investigation.
 The clinical history of the subject is often a guiding factor in this regard. A single test in
isolation may have a little diagnostic value.
 Frequently, a combination of laboratory investigations are employed in LFT. These
include serum bilirubin (conjugated and unconjugated), alanine transaminase,
aspartate transaminase, alkaline phosphatase, J-glutamyl transpeptidase and proteins
(albumin, globulins).
1. Principles of Anatomy and Physiology by Gerard J.Tortora and Bryan Derrickson,
15th Edition, Wiley publication , pg no.
2. Textbook of Pathology by Harsh Mohan , 6th Edition, JAYPEE Publicatuion, pg no.
593- 595.
3. Biochemistry by U. Satyanarayana and U. Chakrapani, 4th Edition, Ellsevier
publication, Pg no. 453-459

More Related Content

What's hot

Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
SMS MEDICAL COLLEGE
 
Excretion of drugs
Excretion of drugsExcretion of drugs
Excretion of drugs
Steffi Thomas
 
Drug excretion new
Drug excretion newDrug excretion new
Drug excretion new
Naser Tadvi
 
Dosage Regimen
Dosage RegimenDosage Regimen
Dosage Regimen
AmrutaSambrekar
 
Excretion renal and non-renal
Excretion renal and non-renalExcretion renal and non-renal
Excretion renal and non-renal
Nagaraju Ravouru
 
Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Schedule t -gmp_(unit-5)
Schedule t -gmp_(unit-5)Schedule t -gmp_(unit-5)
Schedule t -gmp_(unit-5)
Mohammad Khalid
 
Drugs as digestants and carminatives.
Drugs as digestants and carminatives.Drugs as digestants and carminatives.
Drugs as digestants and carminatives.
SnehalChakorkar
 
Pharmaceutical marketing
Pharmaceutical marketingPharmaceutical marketing
Pharmaceutical marketing
Anand Gond
 
Metabolism and excretion
Metabolism and excretionMetabolism and excretion
Metabolism and excretionUrmila Aswar
 
Renal drug excretion
Renal drug excretionRenal drug excretion
Renal drug excretion
amina tariq
 
Non Linear Pharmacokinetics
Non Linear PharmacokineticsNon Linear Pharmacokinetics
Non Linear Pharmacokinetics
AkashVikal
 
General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year
YogeshShelake
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
Dr. Ramesh Bhandari
 
FACTORS AFFECTING DRUG ABSORPTION
FACTORS AFFECTING DRUG  ABSORPTIONFACTORS AFFECTING DRUG  ABSORPTION
FACTORS AFFECTING DRUG ABSORPTION
Drx Suraj Mandal
 
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONBIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
Krutika Pardeshi
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceutics
Suvarta Maru
 

What's hot (20)

Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 
Excretion of drugs
Excretion of drugsExcretion of drugs
Excretion of drugs
 
Drug excretion new
Drug excretion newDrug excretion new
Drug excretion new
 
Dosage Regimen
Dosage RegimenDosage Regimen
Dosage Regimen
 
Excretion renal and non-renal
Excretion renal and non-renalExcretion renal and non-renal
Excretion renal and non-renal
 
Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4Evaluation of Herbal Drugs unit 4
Evaluation of Herbal Drugs unit 4
 
Schedule t -gmp_(unit-5)
Schedule t -gmp_(unit-5)Schedule t -gmp_(unit-5)
Schedule t -gmp_(unit-5)
 
Excretion of drug (VK)
Excretion of drug (VK)Excretion of drug (VK)
Excretion of drug (VK)
 
Drugs as digestants and carminatives.
Drugs as digestants and carminatives.Drugs as digestants and carminatives.
Drugs as digestants and carminatives.
 
Pharmaceutical marketing
Pharmaceutical marketingPharmaceutical marketing
Pharmaceutical marketing
 
Herbal Drug Technology
Herbal Drug TechnologyHerbal Drug Technology
Herbal Drug Technology
 
Metabolism and excretion
Metabolism and excretionMetabolism and excretion
Metabolism and excretion
 
Renal drug excretion
Renal drug excretionRenal drug excretion
Renal drug excretion
 
Non Linear Pharmacokinetics
Non Linear PharmacokineticsNon Linear Pharmacokinetics
Non Linear Pharmacokinetics
 
General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year General pharmacology Diploma in pharmacy second year
General pharmacology Diploma in pharmacy second year
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
 
FACTORS AFFECTING DRUG ABSORPTION
FACTORS AFFECTING DRUG  ABSORPTIONFACTORS AFFECTING DRUG  ABSORPTION
FACTORS AFFECTING DRUG ABSORPTION
 
Evaluation of drugs
Evaluation of drugsEvaluation of drugs
Evaluation of drugs
 
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTIONBIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
BIOPHAMACEUICS- UNIT 1- DRUG ABSORPTION
 
Introduction to biopharmaceutics
Introduction to biopharmaceuticsIntroduction to biopharmaceutics
Introduction to biopharmaceutics
 

Similar to LFTx. clinical pharmacy, PharmD 4th year

LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)
YESANNA
 
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Soujanya Pharm.D
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
Soujanya Pharm.D
 
liver function test
liver function testliver function test
liver function test
Deepthi Prasad
 
Liver fxn
Liver fxnLiver fxn
Liver fxn
Prakash Pokhrel
 
SILD 2021.pdf
SILD 2021.pdfSILD 2021.pdf
SILD 2021.pdf
ElhamAlwagaa
 
Liver Function Test
Liver Function TestLiver Function Test
Liver Function Test
Dr.M.Prasad Naidu
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
soundar rajan
 
Liver function test (LFT)
Liver function test (LFT)Liver function test (LFT)
Liver function test (LFT)
SnehitaPrasad1
 
liver function test
liver function testliver function test
liver function test
SIVASWAROOP YARASI
 
Liver functon tests
Liver functon testsLiver functon tests
Liver functon tests
Zainab&Sons
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
Rishabh Gupta
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
RoshanKumarMahat
 
Liver Functions tests
Liver Functions testsLiver Functions tests
Liver Functions tests
Dr Abdul Qayyum Khan
 
Liver function test (LFT)
Liver function test (LFT)Liver function test (LFT)
Liver function test (LFT)
Maniz Joshi
 
Liver function test by manan sharma
Liver function test by manan sharmaLiver function test by manan sharma
Liver function test by manan sharma
Manan Shastri
 
liverfunctiontest111.pptx
liverfunctiontest111.pptxliverfunctiontest111.pptx
liverfunctiontest111.pptx
ShubhamkumarMaurya7
 
Lft f lect
Lft f lectLft f lect
Lft f lect
sunnychopra10
 
Evaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemiasEvaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemias
Deepujjwal
 
LFT L - 4.pptx
LFT L - 4.pptxLFT L - 4.pptx
LFT L - 4.pptx
PoonumTyagi
 

Similar to LFTx. clinical pharmacy, PharmD 4th year (20)

LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)LIVER FUNCTION TESTS (LFT)
LIVER FUNCTION TESTS (LFT)
 
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
liver function test
liver function testliver function test
liver function test
 
Liver fxn
Liver fxnLiver fxn
Liver fxn
 
SILD 2021.pdf
SILD 2021.pdfSILD 2021.pdf
SILD 2021.pdf
 
Liver Function Test
Liver Function TestLiver Function Test
Liver Function Test
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function test (LFT)
Liver function test (LFT)Liver function test (LFT)
Liver function test (LFT)
 
liver function test
liver function testliver function test
liver function test
 
Liver functon tests
Liver functon testsLiver functon tests
Liver functon tests
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver function tests
Liver function testsLiver function tests
Liver function tests
 
Liver Functions tests
Liver Functions testsLiver Functions tests
Liver Functions tests
 
Liver function test (LFT)
Liver function test (LFT)Liver function test (LFT)
Liver function test (LFT)
 
Liver function test by manan sharma
Liver function test by manan sharmaLiver function test by manan sharma
Liver function test by manan sharma
 
liverfunctiontest111.pptx
liverfunctiontest111.pptxliverfunctiontest111.pptx
liverfunctiontest111.pptx
 
Lft f lect
Lft f lectLft f lect
Lft f lect
 
Evaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemiasEvaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemias
 
LFT L - 4.pptx
LFT L - 4.pptxLFT L - 4.pptx
LFT L - 4.pptx
 

Recently uploaded

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
Kartik Tiwari
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
Wasim Ak
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 

Recently uploaded (20)

Chapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdfChapter -12, Antibiotics (One Page Notes).pdf
Chapter -12, Antibiotics (One Page Notes).pdf
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Normal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of LabourNormal Labour/ Stages of Labour/ Mechanism of Labour
Normal Labour/ Stages of Labour/ Mechanism of Labour
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 

LFTx. clinical pharmacy, PharmD 4th year

  • 1. CLINICAL PHARMACY • Liver Function Tests LFT’s  PharmD Fourth year • By- 2. Vaibhavi Bhatwadekar 15. Khushi Ladda • Government college of pharmacy, Aurangabad
  • 2.  Introduction - anatomy and physiology  Functions of liver  Goals of test  LFT’s  Drug induced liver diseases  Reference
  • 3. INTRODUCTION- Anatomy and physiology-  Liver is the largest organ of the body, dark-reddish in colour.  The liver is located in the upper right hand portion of the abdominal cavity, Beneath the diaphragm and on top of the stomach, right kidney and intestine.  Weighing about 1400-1600 grams in males and 1200-1400 gram in females.  Liver is divided into two lobe that is right lobe and left lobe.  Each lobe contains a number of lobules.  Each lobule is made of the hepatic cells the hepatic cells are the major functional cells in the liver.  Hepatic cells are separated by sinusoids which form part of reticular endothelial system.  Bile canaliculi present between hepatic cells empty into bile ducts.
  • 4. FUNCTIONS OF THE LIVER- 1. Metabolic functions : Liver actively participates in carbohydrate, lipid, protein, mineral and vitamin metabolisms. 2. Excretory functions : Bile pigments, bile salts and cholesterol are excreted in the bile into intestine. 3. Protective functions and detoxification : Kupffer cells of liver perform phagocytosis to eliminate foreign compounds. Ammonia is detoxified to urea. Liver is responsible for the metabolism of xenobiotics (detoxification). 4. Hematological functions : Liver participates in the formation of blood (particularly in the embryo), synthesis of plasma proteins (including blood clotting factors) and destruction of erythrocytes. 5. Storage functions : Glycogen, vitamins A, D and B12 and trace element iron are stored
  • 5. GOALS OF THE LFT’S- 1. To detect the presence of liver disease. 2. To distinguish among different types of liver diseases. 3. To detect the level of the disease whether the mild, moderate or severe 4. To follow the response of the treatment. 5. LFT are employed for accurate diagnosis, to assess the severity of damage, to judge prognosis and to evaluate the therapy.
  • 6.
  • 7. LFT’S-  The liver function tests are the biochemical investigations to assess the capacity of the liver to carry out any of the function its performs.  The major liver function tests may be classified as follows :  1. Tests based on excretory function— Measurement of bile pigments, bile salts, bromosulphthalein.  2. Tests based on serum enzymes derived from liver—Determination of transaminases, alkaline phosphatase, 5’-nucleotidase, J-glutamyltranspeptidase.  3. Tests based on metabolic capacity— Galactose tolerance, antipyrine clearance.  4. Tests based on synthetic functions— Prothrombin time, serum albumin.  5. Tests based on detoxification—Hippuric acid synthesis.
  • 8.  A byproduct of RBC breakdown.  Inside the liver cells , the bilirubin is conjugated with glucouronic acid to make it water soluble.  High bilirubin levels are observed in gallstones, acute and chgronic hepatitis.  Bilirubin pigment can be detected in serum, faeces and urine.  i) Serum bilirubin estimation is based on van den Bergh diazo reaction by spectrophotometric method. Diazo reagent consists of diazotised sulfanilic acid. Water- soluble conjugated bilirubin gives direct van den Bergh reaction with diazo reagent within one minute, whereas alcohol-soluble unconjugated bilirubin is determined by indirect van den Bergh reaction. Addition of alcohol to the reaction mixture gives positive test for both conjugated and unconjugated bilirubin pigment. The unconjugated bilirubin level is then estimated by subtracting direct bilirubin value from this total value. The serum of normal adults contains less than 1 mg/ dl of total bilirubin, out of which less than 0.25 mg/dl is conjugated bilirubin. Bilirubin level rises in diseases of hepatocytes, obstruction to biliary excretion into the duodenum, in haemolysis, and defects of hepatic uptake and conjugation of bilirubin pigment such as in Gilbert’s disease.
  • 9.  ii) In faeces, excretion of bilirubin is assessed by inspection of stools. Clay-coloured stool due to absence of faecal excretion of the pigment indicates obstructive jaundice.  iii) In urine, conjugated bilirubin can be detected by commercially available ‘dipsticks’, Fouchet’s test, foam test or ictotest tablet method. Bilirubinuria does not occur in normal subjects nor is unconjugated bilirubin excreted in the urine. Bilirubinuria occurs only when there is raised level of conjugated bilirubin (filterable). Its excretion depends upon the level of conjugated bilirubin in plasma that is not proteinbound and is therefore available for glomerular filtration. Bilirubinuria appears in patients of hepatitis before the patient becomes jaundiced.  Serum bilirubin normal values:- Total 0.3-1.3 mg/dl Direct (conjugated) 0.1-0.4 mg/dl Indirect (unconjugated) 0.2-0.9 mg/dl
  • 10.  Urobilinogen is a clourless byproduct of bilirubin reduction.  Urobilinogen is normally excreted in the urine.  Its semiquantitative estimation in the urine can be done by preparing dilutions with Ehrlich’s aldehyde reagent or by ‘dipstick’ method.  An increase in urobilinogen in the urine is found in hepatocellular dysfunctions such as in alcoholic liver disease, cirrhosis and malignancy of the liver.  It is also raised in haemolytic disease and in pyrexia.  In cholestatic jaundice due to complete biliary obstruction, urobilinogen disappears from the urine
  • 11.  Bromsulphalein (BSP) is a dye which is removed from circulation by the same mechanisms of binding, conjugation and excretion as bilirubin.  BSP is injected intravenously and a sample of venous blood 45 minutes later is tested for percentage of injected dye remaining in the blood.  The test is rarely performed nowadays because of the availability of enzyme estimations which are better indicators of hepatic dysfunction.  Presently, the only value of BSP excretion test is in the diagnosis of Dubin-Johnson’s syndrome
  • 12.  Serum alkaline phosphatase is produced by many tissues, especially bone, liver, intestine and placenta and is excreted in the bile.  Most of the normal serum alkaline phosphatase (range 33-96 U/L) is derived from bone.  Elevation in activity of the enzyme can thus be found in diseases of bone, liver and in pregnancy.  In the absence of bone disease and pregnancy, an elevated serum alkaline phosphatase levels generally reflect hepatobiliary disease.  The greatest elevation (3 to 10 times normal) occurs in biliary tract obstruction. Slight to moderate increase is seen in parenchymal liver diseases such as in hepatitis and cirrhosis and in metastatic liver disease.  It is possible to distinguish serum hepatic alkaline phosphatase from bony alkaline phosphatase by fractionation into isoenzymes but this is not routinely done.
  • 13.  The primary source of the enzyme, γ-GT, in serum is the liver.  Its serum level parallels serum alkaline phosphatase and is used to confirm that the elevated serum alkaline phosphatase is of hepatobiliary origin.  Besides its elevation in cholestasis and hepatocellular disease, the levels are high in patients with alcohol abuse even without liver disease.  Normal:- 9-58 IU/L (15-85 U/L)
  • 14.  i) Serum aspartate transaminase or AST (formerly glutamic oxaloacetic transaminase or SGOT): AST or SGOT is a mitochondrial enzyme released from heart, liver, skeletal muscle and kidney. Its normal serum level is 0.20-0.65 μkat/L (12-38 U/L).  ii) Serum alanine transaminase or ALT (formerly glutamic pyruvic transaminase or SGPT): ALT or SGPT is a cytosolic enzyme primarily present in the liver. Its normal serum level is 0.12-0.70 μkat/L (7-41 U/L).  Serum levels of SGOT and SGPT are increased on damage to the tissues producing them. Thus serum estimation of SGPT (ALT) which is fairly specific for liver tissue is of greater value in liver cell injury, whereas SGOT (AST) level may rise in acute necrosis or ischaemia of other organs such as the myocardium, besides liver cell injury.  Transaminase estimations are useful in the early diagnosis of viral hepatitis. Very high levels are seen in extensive acute hepatic necrosis such as in severe viral hepatitis and acute cholestasis. Alcoholic liver disease and cirrhosis are associated with mild to moderate elevation of transaminases
  • 15.  Albumin is solely synthesized by the liver.  It has a half-life of about 20-25 days, therefore, it is a good marker to assess chronic (and not acute) liver damage.  Low serum albumin is commonly observed in patients with severe liver damage. It must, however, be noted that the serum albumin concentration is also decreased due to other factors such as malnutrition.  Normal serum albumin level :- 3.5-5.5 g/dl
  • 16.  Alpha and beta globulins are mainly synthesized by the liver.  They constitute immunoglobulins .  High serum gamma globulin are observed in chronic hepatitis and cirrhosis.  Normal level;- 2.0-3.5 g/dl  Normal Albumin to Globulin ratio(A/G) :- 1.5-3:1
  • 17.  The liver synthesizes all the factors concerned with blood clotting.  A decrease in the concentration of plasma clotting factors is found in the impairment of liver function.  This can be assessed in the laboratory by measuring prothrombin time which is prolonged in patients with liver damage, compared to normal.  The half-lives of clotting factors are relatively short (5-72 hrs.), therefore, changes in prothrombin time occur quickly. Hence, this test is useful to assess acute as well as chronic liver damages; besides its help in the prognosis.  Vitamin K is required for the synthesis of blood clotting factors II, VII, IX and X. Therefore, vitamin K deficiency can also cause prolonged prothrombin time which must be ruled out, before drawing conclusions on the liver functions. This is done by measuring prothrombin time before and after administration of vitamin K.
  • 18.  The choice of biochemical tests to measure liver functions mostly depends on the purpose of the investigation.  The clinical history of the subject is often a guiding factor in this regard. A single test in isolation may have a little diagnostic value.  Frequently, a combination of laboratory investigations are employed in LFT. These include serum bilirubin (conjugated and unconjugated), alanine transaminase, aspartate transaminase, alkaline phosphatase, J-glutamyl transpeptidase and proteins (albumin, globulins).
  • 19.
  • 20. 1. Principles of Anatomy and Physiology by Gerard J.Tortora and Bryan Derrickson, 15th Edition, Wiley publication , pg no. 2. Textbook of Pathology by Harsh Mohan , 6th Edition, JAYPEE Publicatuion, pg no. 593- 595. 3. Biochemistry by U. Satyanarayana and U. Chakrapani, 4th Edition, Ellsevier publication, Pg no. 453-459